PDCD1 and cancer: Overall, the cumulative demonstrations in the current study confirm the deleterious effect of R38C, D61V, R94C, and D117V on the PD-1 protein structure and binding affinity accounting for the impact of mutation on cancer progression and consecutively on resistance to drugs.